TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 49 filers reported holding TRANSLATE BIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $44,000 | -80.6% | 2,625 | -75.1% | 0.00% | – |
| Q4 2020 | $227,000 | +404.4% | 10,547 | +233.2% | 0.00% | – |
| Q3 2020 | $45,000 | -35.7% | 3,165 | -21.9% | 0.00% | – |
| Q2 2020 | $70,000 | +70.7% | 4,050 | -18.5% | 0.00% | – |
| Q4 2019 | $41,000 | +28.1% | 4,971 | +56.5% | 0.00% | – |
| Q3 2019 | $32,000 | +3.2% | 3,176 | +28.3% | 0.00% | – |
| Q2 2019 | $31,000 | +3000.0% | 2,475 | +1667.9% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 140 | +105.9% | 0.00% | – |
| Q3 2018 | $1,000 | – | 68 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,833,120 | $52,169,000 | 8.78% |
| Copernicus Capital Management, LLC | 227,719 | $3,099,000 | 2.95% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $29,708,000 | 2.67% |
| Baupost Group | 18,044,239 | $242,393,000 | 2.62% |
| Prosight Management, LP | 282,100 | $3,839,000 | 1.83% |
| RTW INVESTMENTS, LP | 3,745,286 | $50,973,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 943,339 | $12,839,000 | 1.16% |
| DAFNA Capital Management LLC | 190,930 | $2,599,000 | 0.84% |
| Endurant Capital Management LP | 176,710 | $2,405,000 | 0.71% |
| Artal Group S.A. | 1,400,000 | $19,054,000 | 0.46% |